Jeffrey Gelfand, MD

Professor of Clin Neurology
Neurology
+1 415 502-7215

Dr. Gelfand is a Professor of Neurology at UCSF. He specializes in caring for patients with a wide range of neuroinflammatory and neurodegenerative disorders. Dr. Gelfand conducts clinical research, including clinical trials, focused on advancing new treatments for neuroimmunological diseases and restoring neurological function. Dr. Gelfand is also an award-winning medical educator.

Dr. Gelfand received an A.B. in history from Princeton University, graduating summa cum laude and Phi Beta Kappa. He received his M.D. from Harvard Medical School. He completed an internship in internal medicine, residency in neurology, and subspecialty fellowship training in MS/neuroimmunology, all at UCSF. Dr. Gelfand went on to earn a Masters in Advanced Study in clinical research at UCSF. He is board-certified in Neurology.

Dr. Gelfand serves as Medical Director of the UCSF MS and Neuroinflammation Clinic. Dr. Gelfand is also the clinical director of the UCSF Center for Encephalitis and Meningitis (CEM). He is a Coach medical educator in the UCSF Medical School Bridges curriculum. Dr. Gelfand is a recipient of the Robert B. Layzer teaching award (2014), which is voted on annually by UCSF Neurology Department residents; an Excellence in Teaching Award from the UCSF Haile T. Debas Academy of Medical Educators (2015); and was inducted into the UCSF Haile T. Debas Academy of Medical Educators (2020). He served as the Program Director of the UCSF MS Center Clinical Fellowship Training Program for a decade (through 2023), helping to train a new generation of specialists in the field.

Dr. Gelfand is a Fellow of the American Academy of Neurology (FAAN). In 2023 he was elected Chair of the American Academy of Neurology Autoimmune Neurology section.

Publications: 

Anti-RGS8 paraneoplastic cerebellar ataxia is preferentially associated with a particular subtype of Hodgkin's lymphoma.

Journal of neurology

Peter E, Ciano-Petersen NL, Do LD, Perrot J, Ngo T, Pluvinage J, Bartley CM, Zorn KC, Miske R, Scharf M, Villagrán-García M, Farina A, Rogemond V, Antoine JC, Tranchant C, Dubois V, DeRisi JL, Pleasure SJ, Wilson MR, Gelfand JM, Traverse-Glehen A, Honnorat J, Desestret V

Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO).

Frontiers in neurology

Lee ST, Abboud H, Irani SR, Nakajima H, Piquet AL, Pittock SJ, Yeh EA, Wang J, Rajan S, Overell J, Smith J, St Lambert J, El-Khairi M, Gafarova M, Gelfand JM

Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency.

Science translational medicine

Pluvinage JV, Ngo T, Fouassier C, McDonagh M, Holmes BB, Bartley CM, Kondapavulur S, Hurabielle C, Bodansky A, Pai V, Hinman S, Aslanpour A, Alvarenga BD, Zorn KC, Zamecnik C, McCann A, Asencor AI, Huynh T, Browne W, Tubati A, Haney MS, Douglas VC, Louine M, Cree BAC, Hauser SL, Seeley W, Baranzini SE, Wells JA, Spudich S, Farhadian S, Ramachandran PS, Gillum L, Hales CM, Zikherman J, Anderson MS, Yazdany J, Smith B, Nath A, Suh G, Flanagan EP, Green AJ, Green R, Gelfand JM, DeRisi JL, Pleasure SJ, Wilson MR

An autoantibody signature predictive for multiple sclerosis.

Nature medicine

Zamecnik CR, Sowa GM, Abdelhak A, Dandekar R, Bair RD, Wade KJ, Bartley CM, Kizer K, Augusto DG, Tubati A, Gomez R, Fouassier C, Gerungan C, Caspar CM, Alexander J, Wapniarski AE, Loudermilk RP, Eggers EL, Zorn KC, Ananth K, Jabassini N, Mann SA, Ragan NR, Santaniello A, Henry RG, Baranzini SE, Zamvil SS, Sabatino JJ, Bove RM, Guo CY, Gelfand JM, Cuneo R, von Büdingen HC, Oksenberg JR, Cree BAC, Hollenbach JA, Green AJ, Hauser SL, Wallin MT, DeRisi JL, Wilson MR

Clinical presentation and diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: a literature analysis of case studies.

Frontiers in neurology

Papapetropoulos S, Gelfand JM, Konno T, Ikeuchi T, Pontius A, Meier A, Foroutan F, Wszolek ZK

Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.

JAMA neurology

Cross AH, Gelfand JM, Thebault S, Bennett JL, von Büdingen HC, Cameron B, Carruthers R, Edwards K, Fallis R, Gerstein R, Giacomini PS, Greenberg B, Hafler DA, Ionete C, Kaunzner UW, Kodama L, Lock C, Longbrake EE, Musch B, Pardo G, Piehl F, Weber MS, Yuen S, Ziemssen T, Bose G, Freedman MS, Anania VG, Ramesh A, Winger RC, Jia X, Herman A, Harp C, Bar-Or A

Development of an LC-MS/MS method to measure sphingolipids in CSF from patients with multiple sclerosis.

Molecular pharmacology

Perez-Paramo YX, Dufield D, Veeramachaneni R, Parkhurst E, Harp C, Ramesh A, Winger RC, Cross AH, Gelfand JM, Bar-Or A, Mathews WR, Anania VG

A Closed-Loop Falls Monitoring and Prevention App for Multiple Sclerosis Clinical Practice: Human-Centered Design of the Multiple Sclerosis Falls InsightTrack.

JMIR Human Factors

Block VJ, Koshal K, Wijangco J, Miller N, Sara N, Henderson K, Reihm J, Gopal A, Mohan SD, Gelfand JM, Guo CY, Oommen L, Nylander A, Rowson JA, Brown E, Sanders S, Rankin K, Lyles CR, Sim I, Bove R

"Self-care selfies": Patient-uploaded videos capture meaningful changes in dexterity over 6?months.

Annals of clinical and translational neurology

Gopal A, Torres WO, Winawer I, Poole S, Balan A, Stuart HS, Fritz NE, Gelfand JM, Allen DD, Bove R

Detection of High-Risk Paraneoplastic Antibodies Against TRIM9 and TRIM67 proteins.

Annals of neurology

Bartley CM, Ngo TT, Do LD, Zekeridou A, Dandekar R, Muñiz-Castrillo S, Alvarenga BD, Zorn KC, Tubati A, Pinto AL, Browne WD, Hullett PW, Terrelonge M, Schubert RD, Piquet AL, Binxia Y, Montalvo Perero MJ, Kung AF, Mann SA, Shah MP, Geschwind MD, Gelfand JM, DeRisi JL, Pittock SJ, Honnorat J, Pleasure SJ, Wilson MR

Characteristics of Progressive Multifocal Leukoencephalopathy Associated With Sarcoidosis Without Therapeutic Immune Suppression.

JAMA neurology

McEntire CRS, Fletcher A, Toledano M, Epstein S, White E, Tan CS, Mao-Draayer Y, Banks SA, Aksamit AJ, Gelfand JM, Thakur KT, Anand P, Cortese I, Bhattacharyya S

A Predictive Autoantibody Signature in Multiple Sclerosis.

medRxiv : the preprint server for health sciences

Zamecnik CR, Sowa GM, Abdelhak A, Dandekar R, Bair RD, Wade KJ, Bartley CM, Tubati A, Gomez R, Fouassier C, Gerungan C, Alexander J, Wapniarski AE, Loudermilk RP, Eggers EL, Zorn KC, Ananth K, Jabassini N, Mann SA, Ragan NR, Santaniello A, Henry RG, Baranzini SE, Zamvil SS, Bove RM, Guo CY, Gelfand JM, Cuneo R, von Büdingen HC, Oksenberg JR, Cree BA, Hollenbach JA, Green AJ, Hauser SL, Wallin MT, DeRisi JL, Wilson MR

Association of Daily Physical Activity with Cervical Spinal Cord Areas in Multiple Sclerosis.

Multiple sclerosis and related disorders

Valerie J Block, Shuiting Cheng, Jeremy Juwono, Richard Cuneo, Gina Kirkish, Amber M Alexander, Mahir Khan, Amit Akula, Eduardo Caverzasi, Nico Papinutto, William A Stern, San Francisco MS-EPIC Team University of California, Mark J Pletcher, Greg M Marcus, Jeffrey E Olgin, Stephen L Hauser, Jeffrey M Gelfand, Riley Bove, Bruce AC Cree, Roland G Henry

Dual ankyrinG and subpial autoantibodies in a man with well-controlled HIV infection with steroid-responsive meningoencephalitis: A case report.

Frontiers in neurology

Bartley CM, Ngo TT, Cadwell CR, Harroud A, Schubert RD, Alvarenga BD, Hawes IA, Zorn KC, Hunyh T, Teliska LH, Kung AF, Shah S, Gelfand JM, Chow FC, Rasband MN, Dubey D, Pittock SJ, DeRisi JL, Wilson MR, Pleasure SJ

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.

Proceedings of the National Academy of Sciences of the United States of America

Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson KR, Kakara M, Zuroff L, Bennett JL, von B?dingen HC, Carruthers R, Edwards KR, Fallis R, Giacomini PS, Greenberg BM, Hafler DA, Ionete C, Kaunzner UW, Lock CB, Longbrake EE, Pardo G, Piehl F, Weber MS, Ziemssen T, Jacobs D, Gelfand JM, Cross AH, Cameron B, Musch B, Winger RC, Jia X, Harp CT, Herman A, Bar-Or A

Autoimmune Encephalitis Misdiagnosis in Adults.

JAMA neurology

Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A, Toledano M, Turner LE, Vernino S, Irani SR

Remote Observational Research for Multiple Sclerosis: A Natural Experiment.

Neurology(R) neuroimmunology & neuroinflammation

Bove R, Poole S, Cuneo R, Gupta S, Sabatino J, Harms M, Cooper T, Rowles W, Miller N, Gomez R, Lincoln R, McPolin K, Powers K, Santaniello A, Renschen A, Bevan CJ, Gelfand JM, Goodin DS, Guo CY, Romeo AR, Hauser SL, Campbell Cree BA, UCSF MS-EPIC Team

Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)

Block VJ, Cheng S, Juwono J, Cuneo R, Kirkish G, Alexander AM, Khan M, Akula A, Caverzasi E, Papinutto N, Stern WA, Pletcher MJ, Marcus GM, Olgin JE, Hauser SL, Gelfand JM, Bove R, Cree BA, Henry RG

Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry

Abdelhak A, Cordano C, Boscardin WJ, Caverzasi E, Kuhle J, Chan B, Gelfand JM, Yiu HH, Oertel FC, Beaudry-Richard A, Condor Montes S, Oksenberg JR, Lario Lago A, Boxer A, Rojas-Martinez JC, Elahi FM, Chan JR, Green AJ

Making Every Step Count: Minute-by-Minute Characterization of Step Counts Augments Remote Activity Monitoring in People With Multiple Sclerosis.

Frontiers in neurology

Block VJ, Waliman M, Xie Z, Akula A, Bove R, Pletcher MJ, Marcus GM, Olgin JE, Cree BAC, Gelfand JM, Henry RG

Transitioning From S1P Receptor Modulators to B Cell-Depleting Therapies in Multiple Sclerosis: Clinical, Radiographic, and Laboratory Data.

Neurology(R) neuroimmunology & neuroinflammation

Rowles WM, Hsu WY, McPolin K, Li A, Merrill S, Guo CY, Green AJ, Gelfand JM, Bove RM

A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial.

Multiple sclerosis and related disorders

Bove R, Anderson A, Rowles W, Rankin KA, Hills NK, Carleton M, Cooper J, Cree BAC, Gelfand JM, Graves JS, Henry RG, Krysko KM, Rush G, Zamvil SS, Joffe H, Chan JR, Green AJ

Human Leukocyte Antigen Association Study Reveals DRB1*04:02 Effects Additional to DRB1*07:01 in Anti-LGI1 Encephalitis.

Neurology(R) neuroimmunology & neuroinflammation

Peris Sempere V, Muñiz-Castrillo S, Ambati A, Binks S, Pinto AL, Rogemond V, Pittock SJ, Dubey D, Geschwind MD, Gelfand JM, Dilwali S, Lee ST, Knight J, Elliott KS, Irani S, Honnorat J, Mignot E

Spinal cord atrophy predicts progressive disease in relapsing multiple sclerosis.

Annals of neurology

Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono J, Bevan CJ, Bove RM, Crabtree E, Gelfand JM, Goodin DS, Graves JS, Green AJ, Oksenberg JR, Waubant E, Wilson MR, Zamvil SS, University of California, San Francisco MS-EPIC Team, Cree BA, Hauser SL, Henry RG

Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid.

JAMA neurology

Gu W, Rauschecker AM, Hsu E, Zorn KC, Sucu Y, Federman S, Gopez A, Arevalo S, Sample HA, Talevich E, Nguyen ED, Gottschall M, Nourbakhsh B, Gold CA, Cree BAC, Douglas VC, Richie MB, Shah MP, Josephson SA, Gelfand JM, Miller S, Wang L, Tihan T, DeRisi JL, Chiu CY, Wilson MR

ANA Investigates Therapeutic Advancements in Neuroimmunology.

Annals of neurology

Samudralwar RD, Goss AL, Richie M, Gelfand JM

Neurosarcoidosis: Pathophysiology, Diagnosis, and Treatment.

Neurology(R) neuroimmunology & neuroinflammation

Bradshaw MJ, Pawate S, Koth LL, Cho TA, Gelfand JM

Glucocorticoids for therapeutic immunosuppression: Clinical pearls for the practicing neurologist.

Journal of the neurological sciences

Galati A, Brown ES, Bove R, Vaidya A, Gelfand J

Identifying falls remotely in people with multiple sclerosis.

Journal of neurology

Block VJ, Pitsch EA, Gopal A, Zhao C, Pletcher MJ, Marcus GM, Olgin JE, Hollenbach J, Bove R, Cree BAC, Gelfand JM

Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology.

Neurology. Clinical practice

Hua LH, Obeidat AZ, Amezcua L, Cohen JA, Costello K, Dunn J, Gelfand JM, Goldman MD, Hopkins S, Jeffery D, Krieger S, Newsome SD, Shah S, Sicotte NL, Yadav V, Longbrake EE

Foundational Telemedicine Workshop for First-Year Medical Students Developed During a Pandemic.

MedEdPORTAL : the journal of teaching and learning resources

Cornes S, Gelfand JM, Calton B

Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.

Journal for immunotherapy of cancer

Guidon AC, Burton LB, Chwalisz BK, Hillis J, Schaller TH, Amato AA, Betof Warner A, Brastianos PK, Cho TA, Clardy SL, Cohen JV, Dietrich J, Dougan M, Doughty CT, Dubey D, Gelfand JM, Guptill JT, Johnson DB, Juel VC, Kadish R, Kolb N, LeBoeuf NR, Linnoila J, Mammen AL, Martinez-Lage M, Mooradian MJ, Naidoo J, Neilan TG, Reardon DA, Rubin KM, Santomasso BD, Sullivan RJ, Wang N, Woodman K, Zubiri L, Louv WC, Reynolds KL

Tumour necrosis factor inhibitor monotherapy for CNS neurosarcoidosis.

Journal of neurology, neurosurgery, and psychiatry

UpToDate

Manifestations of systemic lupus erythematosus affecting the peripheral nervous system.

Jeffrey M. Gelfand, Jinoos Yazdany.

UpToDate

Neurologic and neuropsychiatric manifestations of systemic lupus erythematosus.

Jeffrey M. Gelfand, Jinoos Yazdany.

Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology.

Neurology Clinical Practice

Le H. Hua, Ahmed Z. Obeidat, Lilyana Amezcua, Jeffrey A. Cohen, Kathleen Costello, Jeffrey Dunn, Jeffrey M. Gelfand, Myla D. Goldman, Sarah Hopkins, Douglas Jeffery, Stephen Krieger, Scott D. Newsome, Suma Shah, Nancy L. Sicotte, Vijayshree Yadav, Erin E. Longbrake

CoachMS, an innovative closed-loop, interdisciplinary platform to monitor and proactively treat MS symptoms: A pilot study.

Multiple Sclerosis Journal - Experimental Translational and Clinical

Valerie J Block, Arpita Gopal, William Rowles, Chu -Yueh, Jeffrey M Gelfand, Riley Bove

Underutilization of physical therapy for symptomatic women with MS during and following pregnancy.

Multiple sclerosis and related disorders

Block VJ, Mestas O, Anderson A, Singh J, Wylie L, Guo CY, Green AJ, Gelfand JM, Bove R

An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)

Romeo AR, Rowles WM, Schleimer ES, Barba P, Hsu WY, Gomez R, Santaniello A, Zhao C, Pearce JR, Jones JB, Cree BC, Hauser SL, Gelfand JM, Stewart WF, Goodin DS, Bove RM

Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis.

Science immunology

Pröbstel AK, Zhou X, Baumann R, Wischnewski S, Kutza M, Rojas OL, Sellrie K, Bischof A, Kim K, Ramesh A, Dandekar R, Greenfield AL, Schubert RD, Bisanz JE, Vistnes S, Khaleghi K, Landefeld J, Kirkish G, Liesche-Starnecker F, Ramaglia V, Singh S, Tran EB, Barba P, Zorn K, Oechtering J, Forsberg K, Shiow LR, Henry RG, Graves J, Cree BAC, Hauser SL, Kuhle J, Gelfand JM, Andersen PM, Schlegel J, Turnbaugh PJ, Seeberger PH, Gommerman JL, Wilson MR, Schirmer L, Baranzini SE

Retinal INL thickness in multiple sclerosis: a mere marker of neurodegeneration?

Annals of neurology

Cordano C, Yiu HH, Oertel FC, Gelfand JM, Hauser SL, Cree BAC, Green AJ

Effects of COVID-19 “Sheltering in Place” on Activity in People with Multiple Sclerosis.

Neurology Clinical Practice

Valerie J Block, Riley Bove, Jeffrey M Gelfand, Bruce A C Cree

A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis.

Proceedings of the National Academy of Sciences of the United States of America

Ramesh A, Schubert RD, Greenfield AL, Dandekar R, Loudermilk R, Sabatino JJ, Koelzer MT, Tran EB, Koshal K, Kim K, Pröbstel AK, Banerji D, Guo CY, Green AJ, Bove RM, DeRisi JL, Gelfand JM, Cree BAC, Zamvil SS, Baranzini SE, Hauser SL, Wilson MR

Imaging correlates of visual function in multiple sclerosis.

PloS one

Caverzasi E, Cordano C, Zhu AH, Zhao C, Bischof A, Kirkish G, Bennett DJ, Devereux M, Baker N, Inman J, Yiu HH, Papinutto N, Gelfand JM, Cree BAC, Hauser SL, Henry RG, Green AJ

A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development.

Journal of medical Internet research

Schleimer E, Pearce J, Barnecut A, Rowles W, Lizee A, Klein A, Block VJ, Santaniello A, Renschen A, Gomez R, Keshavan A, Gelfand JM, Henry RG, Hauser SL, Bove R

Anti-gamma-aminobutyric acid receptor type A encephalitis: a review.

Current opinion in neurology

Guo CY, Gelfand JM, Geschwind MD

Fixational microsaccades: A quantitative and objective measure of disability in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)

Sheehy CK, Bensinger ES, Romeo A, Rani L, Stepien-Bernabe N, Shi B, Helft Z, Putnam N, Cordano C, Gelfand JM, Bove R, Stevenson SB, Green AJ

Intrathecal B-cell activation in LGI1 antibody encephalitis.

Neurology(R) neuroimmunology & neuroinflammation

Lehmann-Horn K, Irani SR, Wang S, Palanichamy A, Jahn S, Greenfield AL, Dandekar R, Lepennetier G, Michael S, Gelfand JM, Geschwind MD, Wilson MR, Zamvil SS, von Büdingen HC

Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented glia.

Brain : a journal of neurology

Gelfand JM, Greenfield AL, Barkovich M, Mendelsohn BA, Van Haren K, Hess CP, Mannis GN

Validation of a consumer-grade activity monitor for continuous daily activity monitoring in individuals with multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical

Block VJ, Zhao C, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Henry R, Gelfand JM, Cree BA

Exploratory proteomic analysis implicates the alternative complement cascade in primary CNS vasculitis.

Neurology

Mandel-Brehm C, Retallack H, Knudsen GM, Yamana A, Hajj-Ali RA, Calabrese LH, Tihan T, Sample HA, Zorn KC, Gorman MP, Madan Cohen J, Sreih AG, Marcus JF, Josephson SA, Douglas VC, Gelfand JM, Wilson MR, DeRisi JL

Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis.

The New England journal of medicine

Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, Neuhaus J, Federman S, Stryke D, Briggs B, Langelier C, Berger A, Douglas V, Josephson SA, Chow FC, Fulton BD, DeRisi JL, Gelfand JM, Naccache SN, Bender J, Dien Bard J, Murkey J, Carlson M, Vespa PM, Vijayan T, Allyn PR, Campeau S, Humphries RM, Klausner JD, Ganzon CD, Memar F, Ocampo NA, Zimmermann LL, Cohen SH, Polage CR, DeBiasi RL, Haller B, Dallas R, Maron G, Hayden R, Messacar K, Dominguez SR, Miller S, Chiu CY

Multiple sclerosis and sarcoidosis: A case for coexistence.

Neurology. Clinical practice

Tyshkov C, Pawate S, Bradshaw MJ, Kimbrough DJ, Chitnis T, Gelfand JM, Ryerson LZ, Kister I

GABAA receptor autoimmunity: A multicenter experience.

Neurology(R) neuroimmunology & neuroinflammation

O'Connor K, Waters P, Komorowski L, Zekeridou A, Guo CY, Mgbachi VC, Probst C, Mindorf S, Teegen B, Gelfand JM, Geschwind MD, Lennon V, Pittock SJ, McKeon A

Silent progression in disease activity-free relapsing multiple sclerosis.

Annals of neurology

Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL

Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis.

JAMA network open

Block VJ, Bove R, Zhao C, Garcha P, Graves J, Romeo AR, Green AJ, Allen DD, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Cree BAC, Gelfand JM

pRNFL as a marker of disability worsening in the medium/long term in patients with MS.

Neurology(R) neuroimmunology & neuroinflammation

Cordano C, Nourbakhsh B, Devereux M, Damotte V, Bennett D, Hauser SL, Cree BAC, Gelfand JM, Green AJ

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group.

JAMA neurology

Stern BJ, Royal W, Gelfand JM, Clifford DB, Tavee J, Pawate S, Berger JR, Aksamit AJ, Krumholz A, Pardo CA, Moller DR, Judson MA, Drent M, Baughman RP

A young man with numbness in arms and legs: From the National Multiple Sclerosis Society Case Conference Proceedings.

Neurology(R) neuroimmunology & neuroinflammation

Romeo AR, Lisak RP, Meltzer E, Fox EJ, Melamed E, Lucas A, Freeman L, Frohman TC, Costello K, Zamvil SS, Frohman EM, Gelfand JM

Clinic to in-home telemedicine reduces barriers to care for patients with MS or other neuroimmunologic conditions.

Neurology(R) neuroimmunology & neuroinflammation

Bove R, Garcha P, Bevan CJ, Crabtree-Hartman E, Green AJ, Gelfand JM

Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)

Bove R, Bevan C, Crabtree E, Zhao C, Gomez R, Garcha P, Morrissey J, Dierkhising J, Green AJ, Hauser SL, Cree BA, Wallin MT, Gelfand JM

Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing.

JAMA neurology

Wilson MR, O'Donovan BD, Gelfand JM, Sample HA, Chow FC, Betjemann JP, Shah MP, Richie MB, Gorman MP, Hajj-Ali RA, Calabrese LH, Zorn KC, Chow ED, Greenlee JE, Blum JH, Green G, Khan LM, Banerji D, Langelier C, Bryson-Cahn C, Harrington W, Lingappa JR, Shanbhag NM, Green AJ, Brew BJ, Soldatos A, Strnad L, Doernberg SB, Jay CA, Douglas V, Josephson SA, DeRisi JL

Distinct HLA associations of LGI1 and CASPR2-antibody diseases.

Brain : a journal of neurology

Binks S, Varley J, Lee W, Makuch M, Elliott K, Gelfand JM, Jacob S, Leite MI, Maddison P, Chen M, Geschwind MD, Grant E, Sen A, Waters P, McCormack M, Cavalleri GL, Barnardo M, Knight JC, Irani SR

Reduced contrast sensitivity among older women is associated with increased risk of cognitive impairment.

Annals of neurology

Ward ME, Gelfand JM, Lui LY, Ou Y, Green AJ, Stone K, Pedula KL, Cummings SR, Yaffe K

Migraine is common in patients with sarcoidosis.

Cephalalgia : an international journal of headache

Gelfand JM, Gelfand AA, Goadsby PJ, Benn BS, Koth LL

Sleep disturbance and symptom burden in sarcoidosis.

Respiratory medicine

Benn BS, Lehman Z, Kidd SA, Miaskowski C, Sunwoo BY, Ho M, Sun S, Ramstein J, Gelfand JM, Koth LL

Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.

Neurology(R) neuroimmunology & neuroinflammation

Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R

The state of clinical research in neurology.

Neurology

Hall DA, Ramos AR, Gelfand JM, Videnovic A, Benatar M, Cahill C, Kluger BM, Goldman M

The importance of early immunotherapy in patients with faciobrachial dystonic seizures.

Brain : a journal of neurology

Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR

Harnessing electronic medical records to advance research on multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)

Damotte V, Lizée A, Tremblay M, Agrawal A, Khankhanian P, Santaniello A, Gomez R, Lincoln R, Tang W, Chen T, Lee N, Villoslada P, Hollenbach JA, Bevan CD, Graves J, Bove R, Goodin DS, Green AJ, Baranzini SE, Cree BA, Henry RG, Hauser SL, Gelfand JM, Gourraud PA

Pleocytosis is not fully responsible for low CSF glucose in meningitis.

Neurology(R) neuroimmunology & neuroinflammation

Baud MO, Vitt JR, Robbins NM, Wabl R, Wilson MR, Chow FC, Gelfand JM, Josephson SA, Miller S

Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.

Neurology

Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, Koth LL, Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, Ammah DJ, Yohannes TH, Hamblin MJ, Venna N, Green AJ, Pawate S

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.

Lancet (London, England)

Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, Henry RG, Hauser SL, Chan JR

Focal cerebral ß-amyloid angiopathy: A distinct clinicopathologic presentation.

Neurology. Clinical practice

Karageorgiou E, Naasan G, Pleasure SJ, Alexandrescu S, Gelfand JM, Tammewar G, Miller BL, Rabinovici GD, Grinberg LT

Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Gelfand JM, Cree BAC, Hauser SL

Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.

Journal of the neurological sciences

Tremblay MA, Villanueva-Meyer JE, Cha S, Tihan T, Gelfand JM

Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort.

Lung

Benn BS, Lehman Z, Kidd SA, Ho M, Sun S, Ramstein J, Arger NK, Nguyen CP, Su R, Gomez A, Gelfand JM, Koth LL

Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.

Science translational medicine

Ward ME, Chen R, Huang HY, Ludwig C, Telpoukhovskaia M, Taubes A, Boudin H, Minami SS, Reichert M, Albrecht P, Gelfand JM, Cruz-Herranz A, Cordano C, Alavi MV, Leslie S, Seeley WW, Miller BL, Bigio E, Mesulam MM, Bogyo MS, Mackenzie IR, Staropoli JF, Cotman SL, Huang EJ, Gan L, Green AJ

Retinal thinning is uniquely associated with medial temporal lobe atrophy in neurologically normal older adults.

Neurobiology of aging

Casaletto KB, Ward ME, Baker NS, Bettcher BM, Gelfand JM, Li Y, Chen R, Dutt S, Miller B, Kramer JH, Green AJ

Continuous daily assessment of multiple sclerosis disability using remote step count monitoring.

Journal of neurology

Block VJ, Lizée A, Crabtree-Hartman E, Bevan CJ, Graves JS, Bove R, Green AJ, Nourbakhsh B, Tremblay M, Gourraud PA, Ng MY, Pletcher MJ, Olgin JE, Marcus GM, Allen DD, Cree BA, Gelfand JM

Long-term evolution of multiple sclerosis disability in the treatment era.

Annals of neurology

Cree BA, Gourraud PA, Oksenberg JR, Bevan C, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves J, Green AJ, Mowry E, Okuda DT, Pelletier D, von Büdingen HC, Zamvil SS, Agrawal A, Caillier S, Ciocca C, Gomez R, Kanner R, Lincoln R, Lizee A, Qualley P, Santaniello A, Suleiman L, Bucci M, Panara V, Papinutto N, Stern WA, Zhu AH, Cutter GR, Baranzini S, Henry RG, Hauser SL

Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis.

Annals of the rheumatic diseases

Miloslavsky EM, Naden RP, Bijlsma JW, Brogan PA, Brown ES, Brunetta P, Buttgereit F, Choi HK, DiCaire JF, Gelfand JM, Heaney LG, Lightstone L, Lu N, Murrell DF, Petri M, Rosenbaum JT, Saag KS, Urowitz MB, Winthrop KL, Stone JH

Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.

Journal of neurology

Balk LJ, Cruz-Herranz A, Albrecht P, Arnow S, Gelfand JM, Tewarie P, Killestein J, Uitdehaag BM, Petzold A, Green AJ

Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.

PloS one

Block VA, Pitsch E, Tahir P, Cree BA, Allen DD, Gelfand JM

Development of a Diagnostic Decision Tree for Rapidly Progressive Dementia (P5.182).

Neurology

Jeffrey Gelfand, Carolyn Fredericks, Natasha Rabinowitz, Katherine Rankin, Christopher Hess, Matteo Paoletti, Joseph Higgins, Gary Williams, Bruce Miller, Howard Rosen, Michael Geschwind

A clinical approach to diagnosis of autoimmune encephalitis.

The Lancet. Neurology

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J

The severe side of the IgG4-related hypertrophic pachymeningitis disease spectrum.

Neurology(R) neuroimmunology & neuroinflammation

Schubert RD, Wood M, Levin MH, Perry A, Gelfand JM

Diagnosing Balamuthia mandrillaris Encephalitis With Metagenomic Deep Sequencing.

Annals of neurology

Wilson MR, Shanbhag NM, Reid MJ, Singhal NS, Gelfand JM, Sample HA, Benkli B, O'Donovan BD, Ali IK, Keating MK, Dunnebacke TH, Wood MD, Bollen A, DeRisi JL

Neurosarcoidosis

In: Samuels M, editor. Scientific American Neurology.

Gelfand JM
Stern BJ

Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.

JAMA neurology

Schlaeger R, Papinutto N, Zhu AH, Lobach IV, Bevan CJ, Bucci M, Castellano A, Gelfand JM, Graves JS, Green AJ, Jordan KM, Keshavan A, Panara V, Stern WA, von Büdingen HC, Waubant E, Goodin DS, Cree BA, Hauser SL, Henry RG

Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients.

Neurology

Höftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, Paredes M, Sabater L, Saiz A, Titulaer MJ, Graus F, Dalmau J

Therapeutic management of severe relapses in multiple sclerosis.

Current treatment options in neurology

Bevan C, Gelfand JM

Encephalitis of unclear origin diagnosed by brain biopsy: a diagnostic challenge.

JAMA neurology

Gelfand JM, Genrich G, Green AJ, Tihan T, Cree BA

Precision medicine in chronic disease management: The multiple sclerosis BioScreen.

Annals of neurology

Gourraud PA, Henry RG, Cree BA, Crane JC, Lizee A, Olson MP, Santaniello AV, Datta E, Zhu AH, Bevan CJ, Gelfand JM, Graves JS, Goodin DS, Green AJ, von Büdingen HC, Waubant E, Zamvil SS, Crabtree-Hartman E, Nelson S, Baranzini SE, Hauser SL

Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.

Neurology(R) neuroimmunology & neuroinflammation

Gelfand JM, Cotter J, Klingman J, Huang EJ, Cree BA

Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD.

The Journal of experimental medicine

Ward ME, Taubes A, Chen R, Miller BL, Sephton CF, Gelfand JM, Minami S, Boscardin J, Martens LH, Seeley WW, Yu G, Herz J, Filiano AJ, Arrant AE, Roberson ED, Kraft TW, Farese RV, Green A, Gan L

Spinal cord gray matter atrophy correlates with multiple sclerosis disability.

Annals of neurology

Schlaeger R, Papinutto N, Panara V, Bevan C, Lobach IV, Bucci M, Caverzasi E, Gelfand JM, Green AJ, Jordan KM, Stern WA, von Büdingen HC, Waubant E, Zhu AH, Goodin DS, Cree BA, Hauser SL, Henry RG

Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.

Annals of neurology

Irani SR, Gelfand JM, Al-Diwani A, Vincent A

Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy.

JAMA neurology

Irani SR, Gelfand JM, Bettcher BM, Singhal NS, Geschwind MD

More than memory impairment in voltage-gated potassium channel complex encephalopathy.

European journal of neurology

Bettcher BM, Gelfand JM, Irani SR, Neuhaus J, Forner S, Hess CP, Geschwind MD

The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG

Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Sweiss N, Crouser E, Morgenthau AS, Lower EE, Azuma A, Ishihara M, Morimoto S, Tetsuo Yamaguchi T, Shijubo N, Grutters JC, Rosenbach M, Li HP, Rottoli P, Inoue Y, Prasse A, Baughman RP, Organ Assessment Instrument Investigators TW

Microcystic inner nuclear layer abnormalities and neuromyelitis optica.

JAMA neurology

Gelfand JM, Cree BA, Nolan R, Arnow S, Green AJ

Migraine and multiple sclerosis: Epidemiology and approach to treatment.

Multiple sclerosis and related disorders

Gelfand AA, Gelfand JM, Goadsby PJ

Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels.

Annals of neurology

Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R, Graus F, Rudy B, Dalmau J

Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.

The Lancet. Neurology

Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA

Microcystic macular oedema in multiple sclerosis is associated with disease severity.

Brain : a journal of neurology

Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ

Neurology Now

Should I see a neurologist for sarcoidosis?

Gelfand JM

Color vision is strongly associated with retinal thinning in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)

Villoslada P, Cuneo A, Gelfand J, Hauser SL, Green A

Ophthalmoplegic "migraine" or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review.

Journal of child neurology

Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ

Vitamin D in African Americans with multiple sclerosis.

Neurology

Gelfand JM, Cree BA, McElroy J, Oksenberg J, Green R, Mowry EM, Miller JW, Hauser SL, Green AJ

Heterogeneous patterns of tissue injury in NARP syndrome.

Journal of neurology

Gelfand JM, Duncan JL, Racine CA, Gillum LA, Chin CT, Zhang Y, Zhang Q, Wong LJ, Roorda A, Green AJ

Cardiac rupture after intravenous t-PA administration in acute ischemic stroke.

Neurocritical care

Dhand A, Nakagawa K, Nagpal S, Gelfand JM, Kim AS, Smith WS, Tihan T

Cerebral perfusion-CT patterns following seizure.

European journal of neurology

Gelfand JM, Wintermark M, Josephson SA

Speech-activated myoclonus masquerading as stuttering.

Neurology

Gelfand JM, Nelson AB, Fross RD, Glass GA